ATARA BIOTHERAPEUTICS, INC. Proceeds from Issuance of Private Placement
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Proceeds from Issuance of Private Placement of $0 for the 6-month period ending 2019-06-30, per its 10-Q filed 2019-08-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfPrivatePlacement · last filed 2019-08-08
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2019-06-30 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2018-12-31 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of private placement for the quarter ending 2018-09-30 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2018 was $293.29M.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2017 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. proceeds from issuance of private placement for fiscal 2016 was $0.00.
| Period end | Proceeds from Issuance of Private Placement 3 month | Proceeds from Issuance of Private Placement 6 month | Proceeds from Issuance of Private Placement 9 month | Proceeds from Issuance of Private Placement 12 month |
|---|---|---|---|---|
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $0.00 10-Q · filed 2019-08-08 | $0.00 derived: sum of 3 quarters · filed 2019-08-08 | $0.00 derived: sum of 4 quarters · filed 2019-08-08 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-09 | $0.00 derived: sum of 2 quarters · filed 2019-05-09 | $0.00 derived: sum of 3 quarters · filed 2019-05-09 | $0.00 derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | $0.00 derived: sum of 3 quarters · filed 2019-08-08 | $293.29M 10-K · filed 2019-02-26 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-08-08 | $293.29M 10-Q · filed 2018-11-06 | $293.29M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $293.29M 10-Q · filed 2019-08-08 | $293.29M derived: sum of 3 quarters · filed 2019-08-08 | $293.29M derived: sum of 4 quarters · filed 2019-08-08 |
| 2018-03-31 | $293.29M 10-Q · filed 2019-05-09 | $293.29M derived: sum of 2 quarters · filed 2019-05-09 | $293.29M derived: sum of 3 quarters · filed 2019-05-09 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $0.00 derived: sum of 2 quarters · filed 2019-02-26 | $0.00 10-K · filed 2019-02-26 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $0.00 10-Q · filed 2018-11-06 | ||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-01 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |